CDKN2B and central nervous system cancer: Our results showed that the combined chromosome 7 gain/10 loss and TERT promoter mutation associated with high INTS9 in the IDH wildtype astrocytoma during the CDKN2A/CDKN2B homozygous deletion in the IDH mutant glioma.